Interview with Founder Mr. Chang-Hai Tsa...
Under the leadership of its founder, Mr. Chang-Hai Tsai, Ever-Supreme (6712) continues to ...
News Center：News
-
Ever-Supreme participated in the 2025 Taiwan Neurosurgical Society Annual Meeting and the 17th First General MeetingEver-Supreme participated in the 2025 Ta...
The 2025 Annual Meeting of the Taiwan Society of Neurosurgery (TSNS) and the 17th First Ge... -
Ever-Supreme won the "2025 Modena Taiwan mRNA Foresight Innovation Award", receiving unanimous recognition from the judges.Ever-Supreme won the "2025 Modena Taiwan...
On November 28th, the Biomedical Translational Research Center (BioTReC) of Academia Sinic... -
Taipei Veterans General Hospital received approval from the Ministry of Health and Welfare on November 25, 2025, for its "Autologous Immune Cell (gamma-delta T)" cell therapy project to treat "Stage IV Solid Cancer".Taipei Veterans General Hospital receive...
Taipei Veterans General Hospital, one of the medical institutions cooperating with Ever-Su... -
Ever-Supreme was awarded the "2025 National Drug Science and Technology Research and Development Award - Pharmaceutical Category - Bronze Award," and its outstanding achievements in the research and development field were unanimously recognized by the judEver-Supreme was awarded the "2025 Natio...
On November 18th, the Ministry of Health and Welfare and the Ministry of Economic Affairs ... -
Professor Esther Troost, Dean of the Medical School of the Technical University of Dresden, Germany, officially visited Ever-Supreme in Taiwan on October 1st.Professor Esther Troost, Dean of the Med...
Ever-Supreme continues to align with international standards. Prof. Esther Troost, Dean of... -
Ever-Supreme International Biotechnology was invited to participate in the 2025 Global Business Forum.Ever-Supreme International Biotechnology...
Ever-Supreme was invited to participate in the 2025 Global Business Forum to jointly explo... -
Ever-Supreme International Biotechnology held a corporate briefing on September 18th, 2025 (Thursday).Ever-Supreme International Biotechnology...
Ever-Supreme International Biotechnology Co., Ltd. held an investor briefing on September ...